# FDA recall D-0342-2021

> **Preferred Pharmaceuticals, Inc.** · Class II · drug recall initiated 2021-04-12.

## Product

Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,

## Reason for recall

Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin

## Distribution

recalled product was distributed to three physicians located CA

## Key facts

- **Recall number:** D-0342-2021
- **Recalling firm:** Preferred Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2021-04-12
- **Report date:** 2021-05-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Anaheim, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0342-2021

## Citation

> AI Analytics. FDA recall D-0342-2021. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0342-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*